X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs GLENMARK PHARMA - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA GLENMARK PHARMA FULFORD INDIA/
GLENMARK PHARMA
 
P/E (TTM) x 398.8 13.6 2,924.1% View Chart
P/BV x 6.2 3.8 162.7% View Chart
Dividend Yield % 0.1 0.3 25.5%  

Financials

 FULFORD INDIA   GLENMARK PHARMA
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
GLENMARK PHARMA
Mar-16
FULFORD INDIA/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs9421,262 74.6%   
Low Rs450672 67.0%   
Sales per share (Unadj.) Rs691.4270.6 255.5%  
Earnings per share (Unadj.) Rs11.524.9 46.1%  
Cash flow per share (Unadj.) Rs15.434.4 44.6%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.30.2 138.9%  
Book value per share (Unadj.) Rs380.0151.3 251.1%  
Shares outstanding (eoy) m3.90282.16 1.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.6 28.2%   
Avg P/E ratio x60.738.9 156.3%  
P/CF ratio (eoy) x45.328.1 161.3%  
Price / Book Value ratio x1.86.4 28.7%  
Dividend payout %17.48.0 217.0%   
Avg Mkt Cap Rs m2,714272,778 1.0%   
No. of employees `0000.410.0 4.4%   
Total wages/salary Rs m50513,782 3.7%   
Avg. sales/employee Rs Th6,073.07,614.9 79.8%   
Avg. wages/employee Rs Th1,137.41,374.8 82.7%   
Avg. net profit/employee Rs Th100.7700.2 14.4%   
INCOME DATA
Net Sales Rs m2,69676,340 3.5%  
Other income Rs m125356 35.2%   
Total revenues Rs m2,82276,696 3.7%   
Gross profit Rs m-4614,172 -0.3%  
Depreciation Rs m152,691 0.6%   
Interest Rs m101,789 0.5%   
Profit before tax Rs m5410,048 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m103,028 0.3%   
Profit after tax Rs m457,019 0.6%  
Gross profit margin %-1.718.6 -9.3%  
Effective tax rate %17.730.1 58.7%   
Net profit margin %1.79.2 18.0%  
BALANCE SHEET DATA
Current assets Rs m1,73859,096 2.9%   
Current liabilities Rs m54540,018 1.4%   
Net working cap to sales %44.325.0 177.1%  
Current ratio x3.21.5 216.1%  
Inventory Days Days4875 64.7%  
Debtors Days Days4119 3.6%  
Net fixed assets Rs m1239,075 0.0%   
Share capital Rs m39282 13.8%   
"Free" reserves Rs m1,44330,281 4.8%   
Net worth Rs m1,48242,703 3.5%   
Long term debt Rs m024,873 0.0%   
Total assets Rs m2,077111,026 1.9%  
Interest coverage x6.76.6 101.5%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x1.30.7 188.8%   
Return on assets %2.67.9 32.9%  
Return on equity %3.016.4 18.3%  
Return on capital %4.317.5 24.6%  
Exports to sales %043.3 0.0%   
Imports to sales %24.57.4 329.1%   
Exports (fob) Rs mNA33,044 0.0%   
Imports (cif) Rs m6595,672 11.6%   
Fx inflow Rs m1736,945 0.0%   
Fx outflow Rs m67361,066 1.1%   
Net fx Rs m-656-24,122 2.7%   
CASH FLOW
From Operations Rs m903,449 2.6%  
From Investments Rs m105-8,802 -1.2%  
From Financial Activity Rs m-146,986 -0.2%  
Net Cashflow Rs m181934 19.3%  

Share Holding

Indian Promoters % 0.0 48.3 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 6.9 55.1%  
FIIs % 0.1 34.4 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.5 201.9%  
Shareholders   4,783 56,727 8.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   VENUS REMEDIES  ORCHID PHARMA LTD  PFIZER  TTK HEALTHCARE  SHASUN PHARMA  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Recovery of Global Markets, Apex Frozen Food IPO & Cues to Watch Out Today(Pre-Open)

Indian stock markets remained range-bound in lacklustre trade on Tuesday as market participants kept to the sidelines in the absence of clear triggers.

Related Views on News

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Other Income Boosts Profit Growth (Quarterly Results Update - Detailed)

Sep 6, 2016

Glenmark has announced its 1QFY17 results. The company has reported 15.8% YoY growth in net sales and 24% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 5-YR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS